Outcomes of critically ill cancer patients with Acinetobacter baumannii infection

Table 2 Demographic and clinical characteristics of the critically ill cancer patients with Acinetobacter baumannii infection on the day of admission to the intensive care unit (initial) according to outcome

Characteristics	Survivors	Nonsurvivors	P
Age, years, mean ± SD	42.6 ± 16.6	48.1 ± 19.3	0.510
Women, n (%)	8 (47)	3 (50)	0.901
APCAHE II score, mean ± SD	12.7 ± 5.0	15.3 ± 7.9	0.357
SOFA score, mean ± SD	8.4 ± 2.4	9.6 ± 2.6	0.318
PEEP, cmH2O	8.4 ± 2.8	7.3 ± 2.3	0.422
Durations of vasopressors	7.59 ± 4.2	11 ± 4.9	0.122
Leukocytes, × 109/L	8.6 ± 6.9	11.6 ± 13.1	0.487
Absolute neutrophil count, cells/mm3	7.5 ± 6.2	10.2 ± 11.2	0.472
Lymphocytes, cells/mm3	682 ± 542	666 ± 871	0.959
Platelets, × 109/L	184.4 ± 149.2	112.8 ± 105.0	0.291
Sodium, mmol/L	138 ± 5.85	135.3 ± 6.4	0.330
Potassium, mmol/L	3.9 ± 0.51	4.0 ± 0.71	0.800
Chloride, mmol/L	109.1 ± 8.74	109.3 ± 4.2	0.967
Lactate, mmo/L	2.01 ± 1.29	5.2 ± 3.2	0.002
Magnesium, mmol/L	0.93 ± 0.24	0.97 ± 0.13	0.722
Phosphorus, mmol/L	1.33 ± 0.46	1.28 ± 0.66	0.816
Hemoglobin, g/L	91.3 ± 19.2	94.5 ± 18.8	0.739
Creatinine, μmol/L	75.8 ± 39.01	133.2 ± 34.4	0.004
Glucose, mmol/L	8.34 ± 3.5	8.09 ± 2.2	0.877
Bilirubin, total, μmol/L	17.8 ± 12.5	22.5 ± 15.5	0.465
Uric acid, μmol/L	219.0 ± 94.0	189.3 ± 149.0	0.576
ARDS, n (%)	13 (76.4)	4 (66.6)	0.632
Number of organ dysfunction (≥ 4)	2 (11.7)	4 (66.6)	0.021
Malignancies
Hematological malignancy, n (%)	8 (47)	6 (100)	0.030
Solid tumor, n (%)	9 (52.9)	0 (0)

APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; IQR: Interquartile range; PEEP: Positive end expiratory pressure; ARDS: Acute respiratory syndrome distress.